Kevin P Rice, Ph.D
Affiliations: | 2005- | Chemistry | Colby College, Waterville, ME, United States |
Google:
"Kevin Rice"Parents
Sign in to add mentor| Michael Matthew Cox | grad student | 1996-2000 | UW Madison (Chemistry Tree) | |
| (DNA pairing mechanisms during homologous recombination events promoted by the Escherichia coli RecA and Saccharomyces cerevisiae Rad51 proteins.) | ||||
| Alan C. Sartorelli | post-doc | 2004 | Yale | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Clarke SR, Naccara AH, Loya AJ, et al. (2019) Abstract 266: Relationship between BAG3 expression and the cytotoxicity of laromustine in HL60 cells Cancer Research. 79: 266-266 |
| Loya AJ, Cincotta DJ, Elkahloun A, et al. (2017) Abstract 2109: Transcriptional analysis of human leukemia cells treated with the experimental anticancer drug laromustine Cancer Research. 77: 2109-2109 |
| Rice KP, Loya AJ, Gross KM. (2016) Abstract 4777: The role of BAG3 in human leukemia cells’ response to the experimental anticancer drug laromustine Cancer Research. 76: 4777-4777 |
| Plaskon D, Guerra RM, McGuckin CP, et al. (2015) Abstract 2444: Directed evolution strategy for generating of novel zinc finger peptides with affinity for gapped DNA Cancer Research. 75: 2444-2444 |
| Ji W, Yang M, Praggastis A, et al. (2014) Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death. Plos One. 9: e103224 |
| Robinson KN, Coe KA, Owumi JE, et al. (2014) Abstract 5498: Changes in expression of DNA repair genes in human leukemia cells treated with laromustine Cancer Research. 74: 5498-5498 |
| Guerra RM, Langenborg KM, Gross KM, et al. (2013) Abstract 2236: A selection strategy for the design of small proteins that can distinguish DNA repair intermediates. Cancer Research. 73: 2236-2236 |
| Rice KP, Klinkerch EJ, Gerber SA, et al. (2012) Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine. Molecular and Cellular Biochemistry. 370: 199-207 |
| Kaye EG, Gross KM, Bellairs J, et al. (2012) Abstract 1764: Changes in apoptotic gene expression in human leukemia cells treated with the anticancer drug Laromustine Cancer Research. 72: 1764-1764 |
| Ghazvinian R, Praggastis VA, Li X, et al. (2011) Abstract 4469: Carbamoylating activity associated with the antitumor prodrug Laromustine inhibits angiogenesis in vitro by inducing ASK1-dependent endothelial cell death Cancer Research. 71: 4469-4469 |